Differential roles of microglia and monocytes in the inflamed central nervous system

Journal of Experimental Medicine

Volumn 211, Issue 8, 2014, Pages 1533-1549

  Yamasaki, Ryo ^a   Lu, Haiyan ^a   Butovsky, Oleg ^b   Ohno, Nobuhiko ^a   Rietsch, Anna M ^a   Cialic, Ron ^b   Wu, Pauline M ^a   Doykan, Camille E ^a   Lin, Jessica ^a,c   Cotleur, Anne C ^a   Kidd, Grahame ^a   Zorlu, Musab M ^a,d   Sun, Nathan ^e   Hu, Weiwei ^a,f   Liu, LiPing ^a   Lee, Jar Chi ^a   Taylor, Sarah E ^g   Uehlein, Lindsey ^a,c   Dixon, Debra ^a,h   Gu, Jinyu ^a   Floruta, Crina M ^a,i   Zhu, Min ^a   Charo, Israel F ^j   Weiner, Howard L ^b   Ransohoff, Richard M ^a,h   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d HACETTEPE UNIVERSITY   (Turkey)

^e VANDERBILT UNIVERSITY   (United States)

^f ZHEJIANG UNIVERSITY   (China)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

ⁱ BAYLOR UNIVERSITY   (United States)

^j GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CENTRAL NERVOUS SYSTEM; DEMYELINATION; ENCEPHALOMYELITIS; EXPERIMENTAL CNS AUTOIMMUNE DISEASE; GENE EXPRESSION PROFILING; HISTOLOGY; MACROPHAGE; MACROPHAGE ACTIVATION; MICROGLIA; MICROGLIA DERIVED MACROPHAGE; MONOCYTE; MONOCYTE DERIVED MACROPHAGE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RANVIER NODE; SCANNING ELECTRON MICROSCOPY;

ANIMALS; CELL SHAPE; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HOMEOSTASIS; HUMANS; INFLAMMATION; KINETICS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROGLIA; MONOCYTES; RANVIER'S NODES; RECEPTORS, CCR2; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84905116959     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20132477     Document Type: Article

References (46)

1. Ajami, B., J.L. Bennett, C. Krieger, W. Tetzlaff, and F.M. Rossi. 2007. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10:1538-1543. http://dx.doi.org/10 .1038/nn2014.
2. Ajami, B., J.L. Bennett, C. Krieger, K.M. McNagny, and F.M. Rossi. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14:1142-1149. http://dx.doi .org/10.1038/nn.2887.
3. Arif, A., P. Chatterjee, R.A. Moodt, and P.L. Fox. 2012. Heterotrimeric GAIT complex drives transcript-selective translation inhibition in murine macrophages. Mol. Cell. Biol. 32:5046-5055. http://dx.doi.org/10 .1128/MCB.01168-12.
4. Bauer, J., I. Huitinga, W. Zhao, H. Lassmann, W.F. Hickey, and C.D. Dijkstra. 1995. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia. 15:437-446. http://dx.doi.org/10.1002/glia.440150407.
5. Brück, W., P. Porada, S. Poser, P. Rieckmann, F. Hanefeld, H.A. Kretzschmar, and H. Lassmann. 1995. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38:788-796. http://dx.doi.org/10 .1002/ana.410380514.
6. Butovsky, O., M.P. Jedrychowski, C.S. Moore, R. Cialic, A.J. Lanser, G. Gabriely, T. Koeglsperger, B. Dake, P.M. Wu, C.E. Doykan, et al. 2014. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat. Neurosci. 17:131-143. http://dx.doi.org/10. 1038/nn.3599.
7. Cardona, A.E., E.P. Pioro, M.E. Sasse, V. Kostenko, S.M. Cardona, I.M. Dijkstra, D. Huang, G. Kidd, S. Dombrowski, R. Dutta, et al. 2006. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9:917-924. http://dx.doi.org/10.1038/nn1715.
8. Chiu, I.M., E.T. Morimoto, H. Goodarzi, J.T. Liao, S. O'Keeffe, H.P. Phatnani, M. Muratet, M.C. Carroll, S. Levy, S. Tavazoie, et al. 2013. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4:385-401. http://dx.doi.org/10.1016/j.celrep.2013.06.018.
9. Denk, W., and H. Horstmann. 2004. Serial block-face scanning electron microscopy to reconstruct three-dimensional tissue nanostructure. PLoS Biol. 2:e329. http://dx.doi.org/10.1371/journal.pbio.0020329.
10. Desmazières, A., N. Sol-Foulon, and C. Lubetzki. 2012. Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology? Mult. Scler. 18:133-137. http://dx.doi.org/10.1177/1352458511434370.
11. Donnelly, D.J., E.E. Longbrake, T.M. Shawler, K.A. Kigerl, W. Lai, C.A. Tovar, R.M. Ransohoff, and P.G. Popovich. 2011. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J. Neurosci. 31:9910-9922. http://dx.doi.org/10.1523/JNEUROSCI.2114-11.2011.
12. Ferguson, B., M.K. Matyszak, M.M. Esiri, and V.H. Perry. 1997. Axonal damage in acute multiple sclerosis lesions. Brain. 120:393-399. http://dx.doi .org/10.1093/brain/120.3.393.
13. Fife, B.T., G.B. Huffnagle, W.A. Kuziel, and W.J. Karpus. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:899-905. http://dx.doi.org/10.1084/jem.192.6.899.
14. Fu, Y., T.J. Frederick, T.B. Huff, G.E. Goings, S.D. Miller, and J.X. Cheng. 2011. Paranodal myelin retraction in relapsing experimental autoimmune encephalomyelitis visualized by coherent anti-Stokes Raman scattering microscopy. J. Biomed. Opt. 16:106006. http://dx.doi.org/10.1117/1.3638180.
15. Gautier, E.L., T. Shay, J. Miller, M. Greter, C. Jakubzick, S. Ivanov, J. Helft, A. Chow, K.G. Elpek, S. Gordonov, et al; Immunological Genome Consortium. 2012. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13:1118-1128. http://dx.doi.org/10.1038/ni.2419.
16. Ginhoux, F., M. Greter, M. Leboeuf, S. Nandi, P. See, S. Gokhan, M.F. Mehler, S.J. Conway, L.G. Ng, E.R. Stanley, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 330:841-845. http://dx.doi.org/10.1126/science.1194637.
17. Gomez Perdiguero, E., C. Schulz, and F. Geissmann. 2013. Development and homeostasis of "resident" myeloid cells: the case of the microglia. Glia. 61:112-120. http://dx.doi.org/10.1002/glia.22393.
18. Hochreiter-Hufford, A., and K.S. Ravichandran. 2013. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb. Perspect. Biol. 5:a008748. http://dx.doi.org/10.1101/cshperspect.a008748.
19. Huang, D., F.D. Shi, S. Jung, G.C. Pien, J. Wang, T.P. Salazar-Mather, T.T. He, J.T. Weaver, H.G. Ljunggren, C.A. Biron, et al. 2006. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20:896-905. http://dx.doi.org/10.1096/fj.05-5465com.
20. Huitinga, I., N. van Rooijen, C.J. de Groot, B.M. Uitdehaag, and C.D. Dijkstra. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172:1025-1033. http://dx.doi.org/10.1084/jem.172.4.1025.
21. Huitinga, I., J.G. Damoiseaux, E.A. Döpp, and C.D. Dijkstra. 1993. Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats. Eur. J. Immunol. 23:709-715. http://dx.doi.org/10.1002/eji.1830230321.
22. Izikson, L., R.S. Klein, I.F. Charo, H.L. Weiner, and A.D. Luster. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192:1075-1080. http://dx.doi.org/10.1084/jem.192.7.1075.
23. Jung, S., J. Aliberti, P. Graemmel, M.J. Sunshine, G.W. Kreutzberg, A. Sher, and D.R. Littman. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-4114. http://dx.doi.org/10 .1128/MCB.20.11.4106-4114.2000.
24. Kivisäkk, P., D.J. Mahad, M.K. Callahan, K. Sikora, C. Trebst, B. Tucky, J. Wujek, R. Ravid, S.M. Staugaitis, H. Lassmann, and R.M. Ransohoff. 2004. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 55:627-638. http://dx.doi.org/10.1002/ana.20049.
25. Kulkarni, M.M. 2011. Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr. Protoc. Mol. Biol. Chapter 25, Unit25B 10.
26. Liu, L., A. Belkadi, L. Darnall, T. Hu, C. Drescher, A.C. Cotleur, D. Padovani-Claudio, T. He, K. Choi, T.E. Lane, et al. 2010. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat. Neurosci. 13:319-326. http://dx.doi.org/10.1038/nn.2491.
27. Meinl, E., T. Derfuss, M. Krumbholz, A.K. Pröbstel, and R. Hohlfeld. 2011. Humoral autoimmunity in multiple sclerosis. J. Neurol. Sci. 306:180-182. http://dx.doi.org/10.1016/j.jns.2010.08.009.
28. Mizutani, M., P.A. Pino, N. Saederup, I.F. Charo, R.M. Ransohoff, and A.E. Cardona. 2012. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188:29-36. http://dx.doi.org/10.4049/jimmunol.1100421.
29. Mukhopadhyay, R., J. Jia, A. Arif, P.S. Ray, and P.L. Fox. 2009. The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem. Sci. 34:324-331. http://dx.doi.org/10.1016/j.tibs.2009.03.004.
30. Nauta, A.J., G. Castellano, W. Xu, A.M. Woltman, M.C. Borrias, M.R. Daha, C. van Kooten, and A. Roos. 2004. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J. Immunol. 173:3044-3050. http://dx.doi.org/10.4049/jimmunol.173.5.3044.
31. Perry, V.H., C. Cunningham, and C. Holmes. 2007. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7:161-167. http://dx.doi.org/10.1038/nri2015.
32. Pino, P.A., and A.E. Cardona. 2011. Isolation of brain and spinal cord mononuclear cells using percoll gradients. J. Vis. Exp. 2348.
33. Ransohoff, R.M. 2007. Microgliosis: the questions shape the answers. Nat. Neurosci. 10:1507-1509. http://dx.doi.org/10.1038/nn1207-1507.
34. Ransohoff, R.M. 2012. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat. Neurosci. 15:1074-1077. http://dx.doi.org/10 .1038/nn.3168.
35. Saederup, N., A.E. Cardona, K. Croft, M. Mizutani, A.C. Cotleur, C.L. Tsou, R.M. Ransohoff, and I.F. Charo. 2010. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS ONE. 5:e13693. http://dx.doi.org/10 .1371/journal.pone.0013693.
36. Savarin, C., S.A. Stohlman, R. Atkinson, R.M. Ransohoff, and C.C. Bergmann. 2010. Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis. J. Virol. 84:4878-4888. http://dx.doi.org/10.1128/JVI.00051-10.
37. Schulz, C., E. Gomez Perdiguero, L. Chorro, H. Szabo-Rogers, N. Cagnard, K. Kierdorf, M. Prinz, B. Wu, S.E. Jacobsen, J.W. Pollard, et al. 2012. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 336:86-90. http://dx.doi.org/10.1126/science.1219179.
38. Serafini, B., B. Rosicarelli, R. Magliozzi, E. Stigliano, E. Capello, G.L. Mancardi, and F. Aloisi. 2006. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 65:124-141.
39. Steinman, L., R. Martin, C. Bernard, P. Conlon, and J.R. Oksenberg. 2002. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25:491-505. http://dx.doi.org/10.1146/annurev.neuro.25.112701.142913.
40. Stoll, G., J.W. Griffin, C.Y. Li, and B.D. Trapp. 1989. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 18:671-683. http://dx.doi.org/10.1007/BF01187086.
41. Trapp, B.D., J. Peterson, R.M. Ransohoff, R. Rudick, S. Mörk, and L. Bö. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278-285. http://dx.doi.org/10.1056/NEJM199801293380502.
42. Trebst, C., T.L. Sørensen, P. Kivisäkk, M.K. Cathcart, J. Hesselgesser, R. Horuk, F. Sellebjerg, H. Lassmann, and R.M. Ransohoff. 2001. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am. J. Pathol. 159:1701-1710. http://dx.doi.org/10.1016/S0002-9440(10)63017-9.
43. Wei, S., S. Nandi, V. Chitu, Y.G. Yeung, W. Yu, M. Huang, L.T. Williams, H. Lin, and E.R. Stanley. 2010. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J. Leukoc. Biol. 88:495-505. http://dx.doi.org/10.1189/jlb.1209822.
44. Williams, K.C., E. Ulvestad, and W.F. Hickey. 1994. Immunology of multiple sclerosis. Clin. Neurosci. 2:229-245.
45. Wynn, T.A., A. Chawla, and J.W. Pollard. 2013. Macrophage biology in development, homeostasis and disease. Nature. 496:445-455. http://dx.doi.org/10.1038/nature12034.
46. Xu, Y., J. Li, G.D. Ferguson, F. Mercurio, G. Khambatta, L. Morrison, A. Lopez-Girona, L.G. Corral, D.R. Webb, B.L. Bennett, and W. Xie. 2009. Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases. Blood. 114:338-345. http://dx.doi.org/10.1182/blood-2009-02-200543.